Chronic Low-back Pain Clinical Trial
— EMOTIVOfficial title:
Evaluation of the Effectiveness of a MOTIVational Support Program After Multidisciplinary Functional Rehabilitation in Chronic Low Back Pain
Chronic low back pain (CLBP) is a major public health problem. Multidisciplinary functional rehabilitation program (FRP), which give patients the skills to better manage pain and return to physical activity, are effective in the short term. In the medium and long term, due to lack of motivation, two thirds of patients stop their physical activity again, causing them to fall back into the vicious circle of pain. Investigators hypothesise that a remote assessment and motivational support program (MSP) based on an application, piloted by a care coordinator, could allow the continued improvement of symptoms and activities observed after the FRP programs, and thus limit the consequences of CLBP for the patient and society. The main objective of this study is to evaluate the effect of the motivational support program EMOTIV, on disability and pain at one year, in chronic low back pain patients who have benefited from a FRP program.
Status | Recruiting |
Enrollment | 150 |
Est. completion date | September 26, 2026 |
Est. primary completion date | September 26, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - age 18 or over - Disabling chronic low back pain: chronic painful patient, that is to say suffering from pain for more than 3 months, having interrupted all physical activity because of low back pain and have an indication for a FRP for low back pain. - Having reached the end of an FRP program - Possession of a smartphone - Fluency in French (writing, reading) - Health insurance coverage (beneficiary or beneficiary) except State Medical Aid. - Patient Informed Consent Signature Exclusion Criteria: - Pregnant woman - Patient refusal - Patient deprived of liberty and patient under legal protection measure (guardianship, guardianship) - Patient participating to another interventional search |
Country | Name | City | State |
---|---|---|---|
France | Hôpital Pitié Salpêtrière | Paris |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique - Hôpitaux de Paris |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Difference in disability and pain between the experimental (SHP) and control (usual care) groups, measured with the Core Outcome Measure Index (COMI) scale at 12 months. | The Core Outcome Measure Index (COMI) was developed from requirements of international back pain experts. According to European experts, the COMI should currently be recommended in assessment of chronic low back pain. This questionnaire assesses pain and disability in low back pain. It includes 9 items and its score is between 0 and 10. Higher scores is the worse outcome. | 12 months after completion of the multidisciplinary functional rehabilitation program | |
Secondary | Evolution of pain | Pain will be measured by a Visual Analogic Scale (VAS) with a question about lumbar pain over the last 7 days. Minimum and maximum values are 0 and 100. | At 3 months, 12 months and 24 months | |
Secondary | Evolution of flexibility | Flexibility will be evaluated by measuring the hand-to-ground distance | At 3 months, 12 months and 24 months | |
Secondary | Evolution of muscular endurance | Muscular endurance will be assessed by measuring Shirado (abdominal endurance). Its score is between 0 and no limit. 0 is the worse outcome. | At 3 months, 12 months and 24 months | |
Secondary | Evolution of muscular endurance | Muscular endurance will be assessed by measuring Sorensen (spinal extensor endurance). Its score is between 0 and no limit. 0 is the worse outcome. | At 3 months, 12 months and 24 months | |
Secondary | Evolution of disability and pain | Disability and pain will be assessed by the Core Outcome Measure Index (COMI) questionnaire. Its score is between 0 and 10. Higher scores is the worse outcome. | At 3 months, 12 months and 24 months | |
Secondary | Evolution of endurance and sports performance (VO2 max) | Endurance and sports performance will be assessed on the treadmill | At 3 months, 12 months and 24 months | |
Secondary | Evolution of the intensity of physical activity | Intensity of physical activity will be assessed by the IPAQ (International Physical Activity Questionnaire). Scoring a high level of physical activity on the IPAQ means the physical activity levels equate to approximately one hour of activity per day or more at least a moderate intensity activity level. | At 3 months, 12 months and 24 months | |
Secondary | Evolution of muscular trophicity in the 2 groups | Muscular trophicity will be done by the measurement of the cross-sectional area (CSA) of the extensor muscles at the level of the upper and lower plateaus of L4 at the lumbar spine | At 3 months and 12 months | |
Secondary | Evolution of the level of anxiety and depression | Level of anxiety and depression will be assessed by the HAD (Hospital Anxiety and Depression) scale.
14 items rated from 0 to 3. Seven questions relate to anxiety (total A) and seven others to the depressive dimension (total D), thus allowing two scores (maximum and worse of each score equal 21) |
At 3 months, 12 months and 24 months | |
Secondary | Evolution of the level of central pain awareness | Two parameters will be used, in accordance with international recommendations on Quantitative Sensory Testings : the pain pressure threshold using an algometer, at a distance from the painful area (forearm), and the temporal summation by repeating a painful stimulus with a calibrated needle (PinPrick) | At inclusion, 3 months, 12 months and 24 months | |
Secondary | Medico-economic analysis | The elements for the medico-economic analysis will be collected on the basis of a questionnaire validated in French. The data collected are : - consultations in general medicine and rheumatology as part of the usual follow-up of patients, - biological or imaging examinations carried out for the spinal problem, - medicinal treatments (drugs, infiltrative procedures) and non-medicinal treatments (physiotherapy, others) carried out for the spinal problem, - any hospitalizations related to the spinal problem | At 3 months, 12 months and 24 months | |
Secondary | Cost of care (i.e, health resource use and related costs or direct costs) | Health resource use will be quantified by the number of consultations, biologic and imaging workups, hospitalisations with their motives, and the list of treatments taken by the patients. It will be valued on the basis of the tariffs of the National Health Insurance Fund (CNAM). Health resource use related costs will be expressed in Euros | At 3 months, 12 months and 24 months | |
Secondary | Cost of care (i.e, health resource use and related costs or direct costs) | Health resource use will be quantified by the number of consultations, biologic and imaging workups, hospitalisations with their motives, and the list of treatments taken by the patients. It will be valued using data from the Common Classification of Medical Acts (CCAM). Health resource use related costs will be expressed in Euros | At 3 months, 12 months and 24 months | |
Secondary | Cost of care (i.e, health resource use and related costs or direct costs) | Health resource use will be quantified by the number of consultations, biologic and imaging workups, hospitalisations with their motives, and the list of treatments taken by the patients. It will be valued using data from the Nomenclature of Medical Biology Acts (NABM). Health resource use related costs will be expressed in Euros | At 3 months, 12 months and 24 months | |
Secondary | Cost of care (i.e, health resource use and related costs or direct costs) | Health resource use will be quantified by the number of consultations, biologic and imaging workups, hospitalisations with their motives, and the list of treatments taken by the patients. It will be valued using data from the national scale of costs (ENC) for hospitalisations. Health resource use related costs will be expressed in Euros | At 3 months, 12 months and 24 months | |
Secondary | Sick leave days | The number of working days off work will be elicited | At 3 months, 12 months and 24 months | |
Secondary | Productivity loss (i.e, sick leave-related costs or indirect costs) | Sick leave days will be valued on the basis of the average daily salaries published each year by the French National Institute of Statistics (INSEE, www.insee.fr). It will be expressed in Euros. | At 3 months, 12 months and 24 months | |
Secondary | Satisfaction with the program | Satisfaction with the program will be measured by a Visual Analogic Scale (VAS). Minimum and maximum values are 0 and 100. The better score is 100. | At 3 months, 12 months and 24 months | |
Secondary | Adherence to the program | Adherence to the program will be evaluated on the number of connection (minimum value 0 and no maximum) | At 3 months, 12 months and 24 months | |
Secondary | Adherence to the program | Adherence to the program will be evaluated on the time of connection (minimum value 0 and no maximum) | At 3 months, 12 months and 24 months | |
Secondary | Adherence to the program | Adherence to the program will be evaluated on number of reminders necessary by the coordinator in case of non connection and/or non attendance at the follow-up (minimum value 0 and non maximum) | At 3 months, 12 months and 24 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05963451 -
Brain, Psychological and Epigenetic Determinants for Optimizing the Treatment of Chronic Low Back Pain
|
||
Completed |
NCT04283370 -
A Study Protocol Comparing a Home Rehabilitation Program Versus e-Health Program in Low Back Pain
|
N/A | |
Completed |
NCT04824547 -
Evaluation of Long-Term Continuity of Exercises in Low Back Pain Individuals
|
N/A | |
Completed |
NCT04046419 -
In Turkish Version "Health Care Providers and Impairment Relationship Scale (HC-PAIRS)"
|
||
Completed |
NCT04399772 -
COgNitive FuncTional Therapy+ for Chronic Low Back paIn
|
N/A | |
Completed |
NCT04555278 -
Combining Non-invasive Brain Stimulation and Exercise to Treat Low Back Pain
|
N/A | |
Completed |
NCT04530071 -
Evaluation of Safety, Tolerability, and Efficacy of CordSTEM-DD in Patients With Chronic Low Back Pain
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06080464 -
Clinician Satisfaction With the VERABANDâ„¢
|
N/A | |
Not yet recruiting |
NCT06347328 -
The Benefits of Posterior Joint Infiltration in Chronic Low Back Pain
|
N/A | |
Not yet recruiting |
NCT04940715 -
Efficacy of Passive Joint Mobilization vs Mobilization With Movement on Pain Processing in Patients With Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT04683718 -
A First in Human Feasibility Study to Evaluate the Safety and Effectiveness of the BIOTRONIK Prospera SCS System With HomeStream Remote Management
|
N/A | |
Recruiting |
NCT05724160 -
Using Non-Weightbearing Stationary Elliptical Machines for Patients With Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT06030128 -
Core Stabilization Exercise Therapy in Chronic Lower Back Back Management in Community Dwelling Older Adults
|
N/A | |
Recruiting |
NCT05846087 -
Mobile App-delivered Sleep Therapy (SleepFix) for Individuals With Chronic Low Back Pain and Insomnia
|
N/A | |
Active, not recruiting |
NCT05396014 -
The BEST Trial: Biomarkers for Evaluating Spine Treatments
|
Phase 4 | |
Active, not recruiting |
NCT06140862 -
Ankle Spine Syndrome "RAFFET Syndrome II
|
N/A | |
Completed |
NCT05512338 -
Motivation and Adherence to Exercise Recommendations
|
N/A | |
Recruiting |
NCT05021146 -
Essential Oil for Chronic Low Back Pain
|
N/A | |
Completed |
NCT06423755 -
Swimming Versus Standard Physiotherapy Care as Rehabilitation Modalities for Persistent Low Back Pain: Feasibility Study
|
N/A | |
Completed |
NCT05120921 -
Osteopathic Single CAse Research for Patients With Chronic Low Back Pain
|
N/A |